Coronavirus Update: $7.8bn Goal To Create Global COVID-19 Strategy
Plus: Third China Vaccine Progresses
World Health Organization brings together global leaders and NGOs - but US and China's absence raises fears of national response to vaccine.
You may also be interested in...
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
Diffusion Pharmaceuticals and WPD Pharmaceuticals get new chief medical officers.
The UK backs the world's first COVID-19 human challenge studies to accelerate research – though the first results will not be ready until mid-2021.